カテゴリー： GlobalInfoResearch, 世界

mRNAワクチンおよび治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global mRNA Vaccine And Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9100023）・商品コード：GIR9100023
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年10月9日（※2024年版があります。お問い合わせください）
・ページ数：102
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、mRNAワクチンおよび治療薬の世界市場について調べ、まとめました。種類別セグメントは、感染症、がん、その他等、用途別セグメントは、病院、研究機関等に区分しました。mRNAワクチンおよび治療薬の世界市場概観、企業動向、企業別mRNAワクチンおよび治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・mRNAワクチンおよび治療薬の市場概観
・mRNAワクチンおよび治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・mRNAワクチンおよび治療薬の企業別販売動向、市場シェア、市場集中度、競争動向
・mRNAワクチンおよび治療薬の世界市場規模
・mRNAワクチンおよび治療薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・mRNAワクチンおよび治療薬のアメリカ市場規模推移
・mRNAワクチンおよび治療薬のカナダ市場規模推移
・mRNAワクチンおよび治療薬のメキシコ市場規模推移
・mRNAワクチンおよび治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・mRNAワクチンおよび治療薬のドイツ市場規模推移
・mRNAワクチンおよび治療薬のイギリス市場規模推移
・mRNAワクチンおよび治療薬のロシア市場規模推移
・mRNAワクチンおよび治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・mRNAワクチンおよび治療薬の日本市場規模推移
・mRNAワクチンおよび治療薬の中国市場規模推移
・mRNAワクチンおよび治療薬の韓国市場規模推移
・mRNAワクチンおよび治療薬のインド市場規模推移
・mRNAワクチンおよび治療薬の東南アジア市場規模推移
・mRNAワクチンおよび治療薬の南米市場分析（ブラジル、アルゼンチン等）
・mRNAワクチンおよび治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・mRNAワクチンおよび治療薬の種類別分析/販売量、売上、市場シェア（感染症、がん、その他）
・mRNAワクチンおよび治療薬の用途別分析/市場規模（病院、研究機関）
・mRNAワクチンおよび治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・mRNAワクチンおよび治療薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The global mRNA Vaccine And Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of mRNA Vaccine And Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the mRNA Vaccine And Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the mRNA Vaccine And Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Moderna Therapeutics
Sangamo Therapeutics
eTheRNA
BioNTech
Argos Therapeutics
CureVac
Translate Bio
In-Cell-Art
Ethris
Tiba Biotechnology

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Infectious Disease
Cancer
Others

Market Segment by Applications, can be divided into
Hospital
Research Institual

【レポートの目次】

Table of Contents

1 mRNA Vaccine And Therapeutics Market Overview
1.1 Product Overview and Scope of mRNA Vaccine And Therapeutics
1.2 Classification of mRNA Vaccine And Therapeutics by Types
1.2.1 Global mRNA Vaccine And Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Types in 2018
1.2.3 Infectious Disease
1.2.4 Cancer
1.2.5 Others
1.3 Global mRNA Vaccine And Therapeutics Market by Application
1.3.1 Global mRNA Vaccine And Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Research Institual
1.4 Global mRNA Vaccine And Therapeutics Market by Regions
1.4.1 Global mRNA Vaccine And Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) mRNA Vaccine And Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) mRNA Vaccine And Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) mRNA Vaccine And Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) mRNA Vaccine And Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) mRNA Vaccine And Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of mRNA Vaccine And Therapeutics (2014-2024)
2 Company Profiles
2.1 Moderna Therapeutics
2.1.1 Business Overview
2.1.2 mRNA Vaccine And Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sangamo Therapeutics
2.2.1 Business Overview
2.2.2 mRNA Vaccine And Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 eTheRNA
2.3.1 Business Overview
2.3.2 mRNA Vaccine And Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 eTheRNA mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 BioNTech
2.4.1 Business Overview
2.4.2 mRNA Vaccine And Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BioNTech mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Argos Therapeutics
2.5.1 Business Overview
2.5.2 mRNA Vaccine And Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Argos Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.6 CureVac
2.6.1 Business Overview
2.6.2 mRNA Vaccine And Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 CureVac mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Translate Bio
2.7.1 Business Overview
2.7.2 mRNA Vaccine And Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Translate Bio mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.8 In-Cell-Art
2.8.1 Business Overview
2.8.2 mRNA Vaccine And Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 In-Cell-Art mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Ethris
2.9.1 Business Overview
2.9.2 mRNA Vaccine And Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ethris mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.10 Tiba Biotechnology
2.10.1 Business Overview
2.10.2 mRNA Vaccine And Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global mRNA Vaccine And Therapeutics Market Competition, by Players
3.1 Global mRNA Vaccine And Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 mRNA Vaccine And Therapeutics Players Market Share
3.2.2 Top 10 mRNA Vaccine And Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global mRNA Vaccine And Therapeutics Market Size by Regions
4.1 Global mRNA Vaccine And Therapeutics Revenue and Market Share by Regions
4.2 North America mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
5 North America mRNA Vaccine And Therapeutics Revenue by Countries
5.1 North America mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
5.2 USA mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe mRNA Vaccine And Therapeutics Revenue by Countries
6.1 Europe mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
6.2 Germany mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Countries
7.1 Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
7.2 China mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
8 South America mRNA Vaccine And Therapeutics Revenue by Countries
8.1 South America mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue mRNA Vaccine And Therapeutics by Countries
9.1 Middle East and Africa mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
10 Global mRNA Vaccine And Therapeutics Market Segment by Type
10.1 Global mRNA Vaccine And Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global mRNA Vaccine And Therapeutics Market Forecast by Type (2019-2024)
10.3 Infectious Disease Revenue Growth Rate (2014-2024)
10.4 Cancer Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global mRNA Vaccine And Therapeutics Market Segment by Application
11.1 Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2014-2019)
11.2 mRNA Vaccine And Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Research Institual Revenue Growth (2014-2019)
12 Global mRNA Vaccine And Therapeutics Market Size Forecast (2019-2024)
12.1 Global mRNA Vaccine And Therapeutics Market Size Forecast (2019-2024)
12.2 Global mRNA Vaccine And Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure mRNA Vaccine And Therapeutics Picture
Table Product Specifications of mRNA Vaccine And Therapeutics
Table Global mRNA Vaccine And Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global mRNA Vaccine And Therapeutics Revenue Market Share by Types in 2018
Figure Infectious Disease Picture
Figure Cancer Picture
Figure Others Picture
Table Global mRNA Vaccine And Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure mRNA Vaccine And Therapeutics Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Research Institual Picture
Table Global Market mRNA Vaccine And Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America mRNA Vaccine And Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe mRNA Vaccine And Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific mRNA Vaccine And Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America mRNA Vaccine And Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa mRNA Vaccine And Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global mRNA Vaccine And Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table Moderna Therapeutics mRNA Vaccine And Therapeutics Type and Applications
Table Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics mRNA Vaccine And Therapeutics Type and Applications
Table Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table eTheRNA Basic Information, Manufacturing Base and Competitors
Table eTheRNA mRNA Vaccine And Therapeutics Type and Applications
Table eTheRNA mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table BioNTech Basic Information, Manufacturing Base and Competitors
Table BioNTech mRNA Vaccine And Therapeutics Type and Applications
Table BioNTech mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table Argos Therapeutics mRNA Vaccine And Therapeutics Type and Applications
Table Argos Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table CureVac Basic Information, Manufacturing Base and Competitors
Table CureVac mRNA Vaccine And Therapeutics Type and Applications
Table CureVac mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Translate Bio Basic Information, Manufacturing Base and Competitors
Table Translate Bio mRNA Vaccine And Therapeutics Type and Applications
Table Translate Bio mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table In-Cell-Art mRNA Vaccine And Therapeutics Type and Applications
Table In-Cell-Art mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Ethris Basic Information, Manufacturing Base and Competitors
Table Ethris mRNA Vaccine And Therapeutics Type and Applications
Table Ethris mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table Tiba Biotechnology mRNA Vaccine And Therapeutics Type and Applications
Table Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global mRNA Vaccine And Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global mRNA Vaccine And Therapeutics Revenue Share by Players (2014-2019)
Figure Global mRNA Vaccine And Therapeutics Revenue Share by Players in 2017
Figure Global mRNA Vaccine And Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players mRNA Vaccine And Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players mRNA Vaccine And Therapeutics Revenue Market Share in 2018
Figure Global mRNA Vaccine And Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global mRNA Vaccine And Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global mRNA Vaccine And Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global mRNA Vaccine And Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global mRNA Vaccine And Therapeutics Revenue Market Share by Regions in 2018
Figure North America mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Table North America mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
Table North America mRNA Vaccine And Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America mRNA Vaccine And Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America mRNA Vaccine And Therapeutics Revenue Market Share by Countries in 2018
Figure USA mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe mRNA Vaccine And Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe mRNA Vaccine And Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe mRNA Vaccine And Therapeutics Revenue Market Share by Countries in 2018
Figure Germany mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure France mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific mRNA Vaccine And Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific mRNA Vaccine And Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific mRNA Vaccine And Therapeutics Revenue Market Share by Countries in 2018
Figure China mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure India mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Table South America mRNA Vaccine And Therapeutics Revenue by Countries (2014-2019)
Table South America mRNA Vaccine And Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America mRNA Vaccine And Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America mRNA Vaccine And Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa mRNA Vaccine And Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa mRNA Vaccine And Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa mRNA Vaccine And Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa mRNA Vaccine And Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa mRNA Vaccine And Therapeutics Revenue and Growth Rate (2014-2019)
Table Global mRNA Vaccine And Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global mRNA Vaccine And Therapeutics Revenue Share by Type (2014-2019)
Figure Global mRNA Vaccine And Therapeutics Revenue Share by Type (2014-2019)
Figure Global mRNA Vaccine And Therapeutics Revenue Share by Type in 2018
Table Global mRNA Vaccine And Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global mRNA Vaccine And Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global Infectious Disease Revenue Growth Rate (2014-2019)
Figure Global Cancer Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global mRNA Vaccine And Therapeutics Revenue by Application (2014-2019)
Table Global mRNA Vaccine And Therapeutics Revenue Share by Application (2014-2019)
Figure Global mRNA Vaccine And Therapeutics Revenue Share by Application (2014-2019)
Figure Global mRNA Vaccine And Therapeutics Revenue Share by Application in 2018
Table Global mRNA Vaccine And Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global mRNA Vaccine And Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Research Institual Revenue Growth Rate (2014-2019)
Figure Global mRNA Vaccine And Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global mRNA Vaccine And Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global mRNA Vaccine And Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
Figure South America mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa mRNA Vaccine And Therapeutics Revenue Market Forecast (2019-2024)


【掲載企業】

Moderna Therapeutics、 Sangamo Therapeutics、 eTheRNA、 BioNTech、 Argos Therapeutics、 CureVac、 Translate Bio、 In-Cell-Art、 Ethris、 Tiba Biotechnology

★調査レポート[mRNAワクチンおよび治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9100023)販売に関する免責事項を必ずご確認ください。
★調査レポート[mRNAワクチンおよび治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • RNAワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101166 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、RNAワクチンの世界市場について調べ、まとめました。種類別セグメントは、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン等、用途別セグメントは、感染症、がん、その他等に区分しました。RNAワクチンの世界市場概観、メーカー動向、メーカー別RNAワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・RNAワクチンの市場概観 ・RNAワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・RNAワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・RNAワクチンの世界市場規模 ・RNAワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・RNAワクチンのアメリカ市場規模推移 ・RNAワクチンのカナダ市場規模推移 ・RNAワクチンのメキシコ市場規模推移 ・RNAワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies. RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research...
  • バイオ医薬品およびワクチン生産の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103412 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、バイオ医薬品およびワクチン生産の世界市場について調べ、まとめました。種類別セグメントは、バイオ医薬品、ワクチン製造等、用途別セグメントは、医薬品、バイオテクノロジー、学術研究機関、その他等に区分しました。バイオ医薬品およびワクチン生産の世界市場概観、企業動向、企業別バイオ医薬品およびワクチン生産シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・バイオ医薬品およびワクチン生産の市場概観 ・バイオ医薬品およびワクチン生産の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・バイオ医薬品およびワクチン生産の企業別販売動向、市場シェア、市場集中度、競争動向 ・バイオ医薬品およびワクチン生産の世界市場規模 ・バイオ医薬品およびワクチン生産の北米市場分析（アメリカ、カナダ、メキシコ等） ・バイオ医薬品およびワクチン生産のアメリカ市場規模推移 ・バイオ医薬品およびワクチン生産のカナダ市場規模推移 ・バイオ医薬品およびワクチン生産のメキシコ市場規模推移 ・バイオ医薬品およびワクチン生産のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease. Scope of the Report: The global Biopharmaceutical and Vaccine Production market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will...
  • 豚熱ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101197 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、豚熱ワクチンの世界市場について調べ、まとめました。種類別セグメントは、組織培養起源、細胞株起源等、用途別セグメントは、政府入札、市場販売等に区分しました。豚熱ワクチンの世界市場概観、メーカー動向、メーカー別豚熱ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・豚熱ワクチンの市場概観 ・豚熱ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・豚熱ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・豚熱ワクチンの世界市場規模 ・豚熱ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・豚熱ワクチンのアメリカ市場規模推移 ・豚熱ワクチンのカナダ市場規模推移 ・豚熱ワクチンのメキシコ市場規模推移 ・豚熱ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Swine fever, also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). Scope of the Report: The worldwide market for Swine Fever Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info...
  • 脂質異常症治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101945 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、脂質異常症治療薬の世界市場について調べ、まとめました。種類別セグメントは、スタチン、非スタチン、併用薬等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。脂質異常症治療薬の世界市場概観、企業動向、企業別脂質異常症治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・脂質異常症治療薬の市場概観 ・脂質異常症治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・脂質異常症治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・脂質異常症治療薬の世界市場規模 ・脂質異常症治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・脂質異常症治療薬のアメリカ市場規模推移 ・脂質異常症治療薬のカナダ市場規模推移 ・脂質異常症治療薬のメキシコ市場規模推移 ・脂質異常症治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In this report, Dyslipidemia Therapeutics are divided into statins, non-statins and combinations drugs. Scope of the Report: The global Dyslipidemia Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play...
  • エキソソーム診断および治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102023 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、エキソソーム診断および治療の世界市場について調べ、まとめました。種類別セグメントは、機器、試薬、ソフトウェア等、用途別セグメントは、診断、治療等に区分しました。エキソソーム診断および治療の世界市場概観、企業動向、企業別エキソソーム診断および治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エキソソーム診断および治療の市場概観 ・エキソソーム診断および治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エキソソーム診断および治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・エキソソーム診断および治療の世界市場規模 ・エキソソーム診断および治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・エキソソーム診断および治療のアメリカ市場規模推移 ・エキソソーム診断および治療のカナダ市場規模推移 ・エキソソーム診断および治療のメキシコ市場規模推移 ・エキソソーム診断および治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body. Scope of the Report: The global Exosome Diagnostics and Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America,...
  • 糖鎖生物学（診断と治療）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102025 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、糖鎖生物学（診断と治療）の世界市場について調べ、まとめました。種類別セグメントは、診断、治療学等、用途別セグメントは、クリニック、病院、その他等に区分しました。糖鎖生物学（診断と治療）の世界市場概観、企業動向、企業別糖鎖生物学（診断と治療）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・糖鎖生物学（診断と治療）の市場概観 ・糖鎖生物学（診断と治療）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・糖鎖生物学（診断と治療）の企業別販売動向、市場シェア、市場集中度、競争動向 ・糖鎖生物学（診断と治療）の世界市場規模 ・糖鎖生物学（診断と治療）の北米市場分析（アメリカ、カナダ、メキシコ等） ・糖鎖生物学（診断と治療）のアメリカ市場規模推移 ・糖鎖生物学（診断と治療）のカナダ市場規模推移 ・糖鎖生物学（診断と治療）のメキシコ市場規模推移 ・糖鎖生物学（診断と治療）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Glycobiology is the study of the structure, biosynthesis, and biology of saccharides that are widely distributed in nature. Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research. Scope of the Report: Glycans are diverse, complex molecules and their functions are determined by their unique structures. Effective enzymatic tools and analytical techniques are required to properly elucidate glycan structure, which can then be correlated to a specific function. Glycosylation defines the adhesive...
  • 薬物乱用治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103563 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、薬物乱用治療薬の世界市場について調べ、まとめました。種類別セグメントは、オピオイド中毒、タバコ/ニコチン中毒、アルコール依存症等、用途別セグメントは、病院＆クリニック、住宅（病院以外）等に区分しました。薬物乱用治療薬の世界市場概観、企業動向、企業別薬物乱用治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・薬物乱用治療薬の市場概観 ・薬物乱用治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・薬物乱用治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・薬物乱用治療薬の世界市場規模 ・薬物乱用治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・薬物乱用治療薬のアメリカ市場規模推移 ・薬物乱用治療薬のカナダ市場規模推移 ・薬物乱用治療薬のメキシコ市場規模推移 ・薬物乱用治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine. Scope of the Report: The global Substance Abuse Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD...
  • 核酸ベース遺伝子治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102917 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、核酸ベース遺伝子治療薬の世界市場について調べ、まとめました。種類別セグメントは、DNA、RNA等、用途別セグメントは、学術および政府研究所、製薬およびバイオテクノロジー企業、受託研究機関、病院および診断センター、その他等に区分しました。核酸ベース遺伝子治療薬の世界市場概観、企業動向、企業別核酸ベース遺伝子治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・核酸ベース遺伝子治療薬の市場概観 ・核酸ベース遺伝子治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・核酸ベース遺伝子治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・核酸ベース遺伝子治療薬の世界市場規模 ・核酸ベース遺伝子治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・核酸ベース遺伝子治療薬のアメリカ市場規模推移 ・核酸ベース遺伝子治療薬のカナダ市場規模推移 ・核酸ベース遺伝子治療薬のメキシコ市場規模推移 ・核酸ベース遺伝子治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Nucleic acid-based molecules are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine. Scope of the Report: The global Nucleic-Acid Based Gene Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot...

    • ◆H&Iグローバルリサーチのお客様（例）◆